Sopris Capital

Sopris Capital Research Investment Thesis Sopris Capital is a 20-year-old venture capital and multi-strategy investment firm founded by Andy Paul with a unique focus on patient, long-term capital. The firm invests its own capital exclusively, giving it flexibility to pursue a disciplined investment approach without traditional fundraising pressures or time-limited fund constraints. The core thesis centers on backing proven management teams and new entrepreneurs in healthcare and technology-enabled businesses, leveraging deep sector expertise, operational networks, and strategic guidance to drive growth and value creation. Organizational Structure Sopris Capital operates as a multi-strategy investment platform with three primary divisions: Venture Capital : Early-stage growth investments in healthcare and SaaS/tech-enabled businesses Private Equity : Growth equity and buyout investments in lower middle-market healthcare companies Real Estate : Real estate investments and development The unique evergreen capital structure (single source of long-term capital) enables patient deployment without typical 10-year fund lifecycles, allowing for strategic flexibility and long-term value creation. Investment Focus - Healthcare & SaaS Healthcare Subsectors Sopris has deep expertise across multiple healthcare verticals: Telemedicine & Care Delivery : Remote healthcare delivery, urgent care, specialty care (dermatology, psychiatric) Home-Based Care : Hospice, home health, geriatric care services Pharmaceutical Technology : Real-world evidence platforms, clinical trial software, pharmaceutical intelligence AI-Driven Healthcare : Medical imaging AI (Paxera Health), oncology data classification, predictive health analytics Behavioral Health : Psychiatric care platforms, addiction treatment, autism therapy services Outpatient Care : High-risk patient management centers, specialized clinical services Healthcare Data : Clinical trial matching platforms, pharmacy claims data, health system intelligence Care Coordination : Chronic disease management, value-based care enablement SaaS & Tech-Enabled Business Focus Healthcare Services SaaS : Staff management, compliance, clinical workflow software Sales & Marketing Technology : CRM platforms for real estate, sales enablement Legal Technology : Legal spend management, contract intelligence Real Estate Technology : Property management software, lead flow platforms Administrative Software : Delinquency management, contact centers Investment Stage & Check Size Stage Focus : Early-to-mid stage (Seed through Series A/B follow-ons) Primary focus: Seed-stage companies with proof of concept and product-market fit Secondary focus: Series A/B opportunities and growth equity Selective pre-seed investments in exceptional teams Check Size : Range appears to be $1M-$10M+ based on portfolio Typical seed investment: $2M-$5M Series A/B follow-ons: $5M-$15M+ Flexible on check size given permanent capital base Investment Criteria Sopris applies a disciplined investment framework: Proven Management Teams : Experienced founders or new entrepreneurs with compelling vision Differentiated Product : Clear competitive advantage and differentiated offering Proof of Concept : Strong evidence of product-market fit with early customer validation Large Addressable Market : Significant TAM with clear expansion pathways Recurring Revenue : Predictable, sustainable revenue model (SaaS/subscription-based preferred) Capital Efficiency : Scalable business model with attractive unit economics Revenue Growth : Demonstrated or highly probable revenue growth trajectory Lead Tendency Primarily Leads Rounds : Based on portfolio analysis, Sopris frequently takes lead investor positions in seed and Series A rounds. Recent examples include lead positions in PaxeraHealth Series A, Clinetic Series A, and other portfolio investments. However, they also participate as co-investors in larger rounds. Portfolio & Recent Activity Portfolio Scale : 45+ active portfolio companies with extensive track record of exits Notable Active Portfolio (Healthcare-focused): Authenticx: AI insights from customer interaction data Azra AI: AI for oncology data classification BEKHealth: Clinical trial software and patient matching Breakthrough Behavior: ABA therapy for autism Clinetic: Real-world evidence for clinical trials DeLorean AI: Predictive AI for enterprise PaxeraHealth: AI-based medical imaging platform (Series A 2024-2025) Tapestry: Telemedicine for skilled nursing facilities Wellstack: Healthcare data platform for value-based care Mindful Care: Same-day psychiatric care AlensiaXR: Mixed-reality for medical education Gotham Healthcare: Medicare plan optimization Realized Exits (15+): Click Notices (SaaS for multifamily), Ethology (digital marketing), Housecall Medical (home care), IkaSystems (health plan software), Lucid (market research), Medical Scribe Systems, Sloan's Lake (managed care), Source Medical, SRSsoft (EMR), Truist (charitable giving platform), and others Recent Activity Timeline : July 2025: Gotham Healthcare investment (most recent listed) 2024-2025: PaxeraHealth Series A lead investment Multiple 2024-2025 investments across portfolio Fund Status : Actively deploying capital with no traditional fund maturity constraints. Based on 20-year history, demonstrated ability to source deals, conduct due diligence, and support portfolio company growth. Team & Expertise Leadership Team : Andrew M. Paul (Founder & CEO) : 30+ years in healthcare PE/VC investing. Senior partner at Welsh Carson (1984-2000, 16 years) leading healthcare investments, 38 healthcare investments with 11 IPOs. Also founded Enhanced Capital Partners ($450M raised) and Enhanced Healthcare Partners ($600M healthcare buyout fund). Mark Groner (Managing Partner) : Joined 2010. Healthcare investment banking background (Citigroup M&A), private equity investing (Linden Capital). Kelley School/Booth MBA. Abinav Sankar (Managing Partner) : Joined 2016. Principal investing since 2012. Private equity at Black Diamond Capital (industrial/consumer buyouts). Macquarie Capital experience across technology, industrials, gaming. Ohio State MBA. Investment Team : Taylor Paul: Principal Vickram Pradhan: Vice President Nicholas Calla: Vice President Tommy Pine: Senior Associate Shayan Khan: Senior Associate Ibrahim Mozawalla: Associate Sophia Hartgrove: Analyst Operations : Bob Mosteller: CFO Jason Smith: Advisor Decision Process & Timeline Decision Structure : Partnership-based decision making with three managing partners (Paul, Groner, Sankar) sharing investment thesis and portfolio oversight Timeline : Not explicitly stated but typical for early-stage VCs is 4-8 weeks for seed investments Board Involvement : Active board participation. Groner and Sankar maintain multiple concurrent board seats across portfolio companies. Geographic Focus Primary Markets : United States (broad, with concentration in Colorado/Mountain West, South Florida, Northeast) Canada (stated in investment criteria) Regional Presence : Headquarters: Aspen, Colorado (409 Aspen Airport Business Center) Denver Office: 255 Fillmore Street, Suite 601, Denver, CO 80206 Miami Office: 252 NW 29th Street, 9th Floor, Miami, FL 33127 Portfolio Geography : Diverse across US (Colorado, Tennessee, North Carolina, Florida, New York, California, Pennsylvania, Massachusetts, Michigan, Wisconsin, and more) Founder & Investment Preferences Founder Profile Preferred : Proven management teams with track records New entrepreneurs with clear vision and domain expertise Operators comfortable with active investor partnership and board involvement Teams seeking long-term partnership over quick exits Company Profile : Capital-efficient models (especially SaaS-based) Strong product-market fit evidence Recurring revenue or clear path to predictable revenue Differentiated positioning Large serviceable addressable markets Value-Add & Support Model Beyond capital, Sopris provides: Strategic Guidance : Direct input on company strategy and growth initiatives Operational Support : Management team building, organizational development Customer Development : Leveraging network to drive customer acquisition Acquisition Strategy : Proactive M&A guidance and transaction support Board Participation : Active board seats or observer rights Network Access : Well-established relationships in healthcare and technology sectors Operational Expertise : Deep sectoral knowledge applied to portfolio company challenges Key Differentiators Patient Capital Structure : Evergreen capital without 10-year fund timeframes enables counter-cyclical investing and long-term value creation Sector Expertise : 30+ years of healthcare investment experience concentrated in senior leadership Multi-Strategy Platform : Unique position to leverage PE and RE teams for portfolio support Active Partnership Model : Not hands-off investors; direct involvement in strategy and operations Track Record : 20-year history with 15+ exits and strong realized returns Geographic Presence : Multiple offices enable on-the-ground support Anti-Thesis Non-recurring revenue models (marketplace-only, transaction-based) Highly capital-intensive businesses (hardware-heavy, infrastructure) Businesses heavily dependent on regulatory changes without clear mitigation Consumer-only applications without B2B recurrence Teams seeking passive investor relationships Recent Market Activity & Positioning Sopris is actively deploying capital in the current market: Focus on AI-driven healthcare solutions (Azra AI, DeLorean AI, Paxera Health) Behavioral health expansion (Mindful Care, behavioral health services) Clinical trial and real-world evidence platforms (Clinetic, BEKHealth, ProofPilot) Healthcare staffing and management (OfficeWorks, Mountain Temp Services) Value-based care enablement (Wellstack, TurningPoint) Confidence Assessment Research confidence: Investment Thesis : High (95%) - Clear articulation across website and team backgrounds Portfolio Companies : High (95%) - Comprehensive portfolio page with 45+ companies listed Team Backgrounds : High (98%) - Detailed biographies with verifiable experience Stage/Check Size : Medium-High (80%) - Inferred from portfolio and investment criteria Lead Tendency : Medium-High (85%) - Based on portfolio analysis and public announcements Geographic Focus : High (95%) - Explicitly stated and offices confirmed Decision Timeline : Low-Medium (60%) - Not explicitly stated AUM/Fund Size : Low (40%) - Permanent capital base, specific amount not disclosed